CytomX Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 251-275 of 794 matching filings.

Per page

25

Current page

11

4

FORM 4

Filing date: 12 Aug 2022
Reporting date: 10 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Aug 2022
Reporting date: 10 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Aug 2022
Reporting date: 10 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Aug 2022
Reporting date: 10 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 04 Aug 2022
Reporting date: 04 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-37587

10-Q

Filing date: 04 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-89140

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date: 29 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-89140

SC 13G filing

Filing date: 25 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Jul 2022
Reporting date: 19 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 13 Jul 2022
Reporting date: 13 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-89140

SC 13G filing

Filing date: 08 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 06 Jul 2022
Reporting date: 06 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 21 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .